Patents Assigned to Rainbow Pharmaceutical SA
  • Uses of ammonium chloride
    Patent number: 8840934
    Abstract: A method to treat a condition in a patient comprising administering to the patient a therapeutically effective amount of a NH4Cl dosage form, a method for stimulating endogenous interferon production, and related methods, systems and dosage form housings.
    Type: Grant
    Filed: January 2, 2009
    Date of Patent: September 23, 2014
    Assignee: Rainbow Pharmaceutical SA
    Inventor: Diamantis Kiassos